Using generative AI, researchers design compounds that can kill drug-resistant bacteria
The team used two different AI approaches to design novel antibiotics, including one that showed promise against MRSA.
Learn about artificial intelligence, GPT usage, prompt engineering and other technology news and updates from Land of GPT. The site aggregates articles from official RSS feeds under their original authorship. Each article has a do-follow link to the original source.
The team used two different AI approaches to design novel antibiotics, including one that showed promise against MRSA.
A new approach for testing multiple treatment combinations at once could help scientists develop drugs for cancer or genetic disorders.
Launched with a gift from the Biswas Family Foundation, the Biswas Postdoctoral Fellowship Program will support postdocs in health and life sciences.
The MIT-MGB Seed Program, launched with support from Analog Devices Inc., will fund joint research projects that advance technology and clinical research.
Trained with a joint understanding of protein and cell behavior, the model could help with diagnosing disease and developing new drugs.
A quarter century after its founding, the McGovern Institute reflects on its discoveries in the areas of neuroscience, neurotechnology, artificial intelligence, brain-body connections, and therapeutics.
FragFold, developed by MIT Biology researchers, is a computational method with potential for impact on biological research and therapeutic applications.
ReviveMed uses AI to gather large-scale data on metabolites — molecules like lipids, cholesterol, and sugar — to match patients with therapeutics.
Junior Katie Spivakovsky describes her path through New Engineering Education Transformation to biomedical research and beyond.
By sidestepping the need for costly interventions, a new method could potentially reveal gene regulatory programs, paving the way for targeted treatments.